Table 3.
rarA primer sequencesa
| PCR amplification site | Primer |
Locationb | Amplicon size (bp) | |
|---|---|---|---|---|
| Forward | Reverse | |||
| Intact rarA gene | ATGAGGGTACTTGTATCCTCC | GTTGCAGAAGATATTGGTTTG | 1169159–1168918 | 241 |
| Intact rarA gene + flanking | CAATGCTCTCTCGAATAGAAA | GTTGCAGAAGATATTGGTTTG | 1169460–1168918 | 542 |
| 5′ rarA gene + flanking | GATCCTCACATCTTCCTTCTC | TCCTTTAGCTGATTTGATGC | 1161570–1161092 | 478 |
| 5′ rarA gene | ATCTTTTACCGATGCTGTTG | TCCTTTAGCTGATTTGATGC | 1161282–1161092 | 190 |
| 3′ rarA gene + flanking | ACATAATGAATATGGCAGGC | CCTTGTGTAAAGTCATTTGTGA | 1185696–1185103 | 593 |
| 3′ rarA gene | TGGAAGAATAACGTTAATAGCA | CCTTGTGTAAAGTCATTTGTGA | 1185696–1185458 | 238 |
rarA primer sequences and characteristics. Sequences for six PCR primer pairs that amplify intact rarA, regions within the 5′ or 3′ split rarA gene, and/or its flanking region. The primer sites within C. botulinum Alaska E43 and the expected amplicon sizes are provided.
Location within C. botulinum Alaska E43 (NC_010723.1).